[Figure: see text].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416801 | PMC |
| http://dx.doi.org/10.1161/CIRCRESAHA.121.319579 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring the Potential of Symmetric Exon Deletion to Treat Non-Ischemic Dilated Cardiomyopathy by Removing Frameshift Mutations in .
Genes (Basel)
June 2022
Research Platform Degenerative Diseases, German Primate Center-Leibniz Institute for Primate Research, 37077 Göttingen, Germany.
Non-ischemic dilated cardiomyopathy (DCM) is one of the most frequent pathologies requiring cardiac transplants. Even though the etiology of this disease is complex, frameshift mutations in the giant sarcomeric protein Titin could explain up to 25% of the familial and 18% of the sporadic cases of DCM. Many studies have shown the potential of genome editing using CRISPR/Cas9 to correct truncating mutations in sarcomeric proteins and have established the grounds for myoediting.
View Article and Find Full Text PDFCardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy.
Circ Res
September 2021
Department of Molecular Biology (A.A., A.C.C., M.C., Z.W., T.N., R.B.-D., E.N.O.), University of Texas Southwestern Medical Center, Dallas, TX.
[Figure: see text].
View Article and Find Full Text PDFToward the correction of muscular dystrophy by gene editing.
Proc Natl Acad Sci U S A
June 2021
Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390;
Recent advances in gene editing technologies are enabling the potential correction of devastating monogenic disorders through elimination of underlying genetic mutations. Duchenne muscular dystrophy (DMD) is an especially severe genetic disorder caused by mutations in the gene encoding dystrophin, a membrane-associated protein required for maintenance of muscle structure and function. Patients with DMD succumb to loss of mobility early in life, culminating in premature death from cardiac and respiratory failure.
View Article and Find Full Text PDFCorrection of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing.
Sci Adv
January 2018
Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Genome editing with CRISPR/Cas9 is a promising new approach for correcting or mitigating disease-causing mutations. Duchenne muscular dystrophy (DMD) is associated with lethal degeneration of cardiac and skeletal muscle caused by more than 3000 different mutations in the X-linked dystrophin gene (). Most of these mutations are clustered in "hotspots.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!